Bethkis Solution
Product Images NDC 10122-820

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Bethkis (NDC 10122-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin Structural Formula (Bethkis 1)

Chemical structure of tobramycin, the active ingredient in BETHKIS 300 mg/4mL solution for respiratory inhalation by Chiesi USA, Inc. The diagram shows the molecular arrangement of tobramycin's atoms and bonds.*

FDA Label Image

Mounting The Mouthpiece Onto The Nebulizer Cup Outlet (Bethkis 10)

An instructional diagram illustrating the assembly of a respiratory inhalation device. The image shows the insertion of a capsule or cartridge into a chamber with a mouthpiece and clamp, demonstrating the preparation step for using the inhalation solution.*

FDA Label Image

Mounting The Inspiratory Valve Cap Onto The Nebulizer Cup Top (Bethkis 11)

An instructional diagram depicting how to assemble or use a respiratory inhalation device, showing a canister or container with a lid being placed on top and a mouthpiece attached to the side handle.*

FDA Label Image

Connecting The Tubing To The Compressor Air Outlet (Bethkis 12)

An instructional illustration showing a hand plugging in a power cord into the Vios device, likely a nebulizer used for inhalation therapy. The image focuses on the connection port and power switch area of the device.*

FDA Label Image

Plugging The Compressor Plug Into The Electrical Outlet (Bethkis 13)

An instructional line drawing showing a hand pulling a two-prong electrical plug from a wall outlet, illustrating the safe disconnection of an electrical device from power.*

FDA Label Image

Pushing The Tubing Onto The Air Intake Of The Nebulizer Cup (Bethkis 14)

An instructional diagram showing a respiratory inhalation device with a mouthpiece, a cylindrical chamber, and an airflow indicator demonstrating how air enters from the bottom and moves through the chamber and mouthpiece for inhalation use.*

FDA Label Image

Turning On The Compressor (Bethkis 15)

An illustration showing a hand plugging in a cable or tube into a device labeled Vios, which is a nebulizer machine used for respiratory inhalation therapy. The device features a power switch and connection ports on the front panel.*

FDA Label Image

Checking A Steady Mist Coming From The Mouthpiece (Bethkis 16)

An instructional diagram showing a hand holding a nebulizer mouthpiece connected to a medication cup. The image depicts the proper handling or setup of the inhalation device for respiratory administration of medication.*

FDA Label Image

Placing The Mouthpiece In The Mouth (Bethkis 17)

An instructional line drawing illustrating the use of a respiratory inhalation device. The image shows a side profile of a person's face using a nebulizer mouthpiece connected by tubing to a nebulizer chamber.*

FDA Label Image

14 Day (Bethkis 18)

The carton label for BETHKIS 300 mg/4 mL (tobramycin inhalation solution) by Chiesi USA, Inc. It is a respiratory inhalation solution packaged in a 28-ampule carton for single-use nebulizer administration. Label instructions include storing in a refrigerator at 2°C to 8°C and discarding each ampule after one use. The label indicates the product is a 14-day supply.*

FDA Label Image

Carton Label (Bethkis 19)

The packaging label for BETHKIS (tobramycin inhalation solution) 300 mg/4 mL, a respiratory inhalation solution by Chiesi USA, Inc. The label indicates it is for oral inhalation by nebulizer, single-use only, with instructions to discard each ampule after one use. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) and note that unopened ampules should be returned to the foil pouch. Each carton contains 56 single-use ampules (28-day supply).*

FDA Label Image

Figure 1 (Bethkis 2)

A line chart comparing the predicted percentage change from baseline in FEV1 over 24 weeks between BETHKIS (tobramycin inhalation solution) and placebo groups in two separate studies. The x-axis represents time in weeks, with periods marked "on drug," and the y-axis shows the adjusted mean percentage change in FEV1 from baseline.*

FDA Label Image

Bethkis Foil Pouch (Bethkis 20)

Label for BETHKIS 300 mg/4 mL Tobramycin Inhalation Solution designed for oral inhalation by nebulizer. The single-use ampule packaging includes 4 mL solution with 300 mg tobramycin, manufactured by Chiesi USA, Inc. Storage instructions specify refrigeration at 2°C to 8°C and protection from intense light.*

FDA Label Image

Bethkis® (tobramycin Inhalation Solution) 300 mg / 4 mL Ampule Label (Bethkis 21)

Label for Bethkis 300 mg/4 mL Tobramycin Inhalation Solution. The label displays the proprietary name Bethkis, strength 300 mg per 4 mL, and identifies the product as Tobramycin Inhalation Solution for respiratory use.*

FDA Label Image

Bethkis Supplies (Bethkis 3)

Illustration showing components of the PARI LC PLUS reusable nebulizer system with a PARI Vios compressor, including labeled parts such as the inspiratory valve cap, nebulizer cup, mouthpiece, tubing, and nose clip, alongside one ampule of BETHKIS (tobramycin inhalation solution) and a clean paper towel.*

FDA Label Image

Foil Pouch (Bethkis 4)

BETHKIS Tobramycin Inhalation Solution 300 mg/4 mL ampules packaged in strips of five unit-dose vials. Label indicates respiratory inhalation use and includes branding with Chiesi USA, Inc. as the labeler. The packaging appears to provide multiple single-use ampules for inhalation therapy.*

FDA Label Image

Separating Bethkis Ampule (Bethkis 5)

Illustration showing hands removing or handling individual blister packs containing ampules of BETHKIS (tobramycin) inhalation solution, 300 mg/4 mL, from a blister tray or packaging. The image demonstrates the physical unit dose packaging for respiratory administration.*

FDA Label Image

Opening Bethkis Ampule (Bethkis 6)

An illustration showing two hands holding a single-dose vial of BETHKIS (tobramycin) 300 mg/4 mL solution for inhalation. One hand holds the vial at the bottom while the other hand removes the top cap, demonstrating how to open the vial for use.*

FDA Label Image

Opening The Nebulizer Cup (Bethkis 7)

An instructional illustration showing hands assembling a nebulizer chamber for inhalation. The diagram labels the nebulizer cup top and outlet, with an arrow indicating the direction of airflow ('2') through the device.*

FDA Label Image

Transferring Bethkis Medicine From The Ampule Into The Nebulizer Cup (Bethkis 8)

An instructional illustration showing hands holding a vial and inserting its contents into a respiratory inhalation device. The image depicts the preparation step for using an inhalation solution, consistent with the use of a product like BETHKIS (tobramycin) solution for inhalation.*

FDA Label Image

Closing The Nebulizer Cup (Bethkis 9)

An instructional diagram showing two hands assembling a nebulizer. One hand holds the nebulizer cup outlet, while the other aligns the nebulizer cup top above it, indicating the steps to connect the parts by moving the top downward.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.